BlackRock’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48.3M | Sell |
13,954,486
-524,312
| -4% | -$1.81M | ﹤0.01% | 2434 |
|
|
2025
Q1 | $37.9M | Sell |
14,478,798
-195,464
| -1% | -$512K | ﹤0.01% | 2499 |
|
|
2024
Q4 | $60.5M | Buy |
14,674,262
+2,932,115
| +25% | +$12.1M | ﹤0.01% | 2311 |
|
|
2024
Q3 | $83.1M | Buy |
11,742,147
+1,199,480
| +11% | +$8.49M | ﹤0.01% | 2163 |
|
|
2024
Q2 | $68.7M | Buy |
10,542,667
+746,457
| +8% | +$4.87M | ﹤0.01% | 2219 |
|
|
2024
Q1 | $81.3M | Buy |
9,796,210
+222,787
| +2% | +$1.85M | ﹤0.01% | 2141 |
|
|
2023
Q4 | $105M | Buy |
9,573,423
+1,243,656
| +15% | +$13.7M | ﹤0.01% | 2011 |
|
|
2023
Q3 | $70.1M | Sell |
8,329,767
-37,961
| -0.5% | -$319K | ﹤0.01% | 2169 |
|
|
2023
Q2 | $105M | Buy |
8,367,728
+432,038
| +5% | +$5.43M | ﹤0.01% | 1993 |
|
|
2023
Q1 | $131M | Sell |
7,935,690
-62,295
| -0.8% | -$1.03M | ﹤0.01% | 1835 |
|
|
2022
Q4 | $119M | Buy |
7,997,985
+1,240,348
| +18% | +$18.5M | ﹤0.01% | 1872 |
|
|
2022
Q3 | $151M | Buy |
6,757,637
+180,459
| +3% | +$4.04M | 0.01% | 1674 |
|
|
2022
Q2 | $110M | Buy |
6,577,178
+602,995
| +10% | +$10.1M | ﹤0.01% | 1925 |
|
|
2022
Q1 | $179M | Sell |
5,974,183
-19,430
| -0.3% | -$582K | ﹤0.01% | 1734 |
|
|
2021
Q4 | $184M | Buy |
5,993,613
+641,001
| +12% | +$19.7M | ﹤0.01% | 1785 |
|
|
2021
Q3 | $169M | Buy |
5,352,612
+812,282
| +18% | +$25.6M | ﹤0.01% | 1832 |
|
|
2021
Q2 | $166M | Buy |
4,540,330
+741,600
| +20% | +$27.1M | ﹤0.01% | 1901 |
|
|
2021
Q1 | $131M | Buy |
3,798,730
+641,756
| +20% | +$22.2M | ﹤0.01% | 2007 |
|
|
2020
Q4 | $131M | Buy |
3,156,974
+1,091,529
| +53% | +$45.4M | ﹤0.01% | 1888 |
|
|
2020
Q3 | $88M | Buy |
+2,065,445
| New | +$88M | ﹤0.01% | 1932 |
|